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Background: Alternate day fasting (ADF; ad libitum intake “feed day” alternated with 75% restriction “fast day”), is
effective for weight loss, but the safety of the diet has been questioned. Accordingly, this study examined occurrences
of adverse events and eating disorder symptoms during ADF.
Findings: Obese subjects (n = 59) participated in an 8-week ADF protocol where food was provided on the fast day.
Body weight decreased (P < 0.0001) by 4.2 ± 0.3%. Some subjects reported constipation (17%), water retention (2%),
dizziness (<20%), and general weakness (<15%). Bad breath doubled from baseline (14%) to post-treatment (29%),
though not significantly. Depression and binge eating decreased (P < 0.01) with ADF. Purgative behavior and fear of
fatness remained unchanged. ADF helped subjects increase (P < 0.01) restrictive eating and improve (P < 0.01) body
image perception.
Conclusions: Therefore, ADF produces minimal adverse outcomes, and has either benign or beneficial effects on
eating disorder symptoms.
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Alternate day fasting (ADF) is an innovative form of diet-
ary restriction capable of decreasing body weight by 4-8%
after 8–12 weeks [1-4]. ADF allows dieters to alternate be-
tween a “feed-day” involving ad libitum food intake, and a
“fast-day” consisting of 75% energy restriction. Although
ADF is effective for weight loss, the safety of the diet has
been questioned. In particular, concerns have been raised
regarding gastrointestinal disturbances, sleep issues, and
problems with energy levels (that may be related to lower
blood sugar levels). ADF has also been criticized for po-
tentially increasing disordered eating behaviors and nega-
tively impacting body image perception. Accordingly, this
study examined the occurrence of adverse events, changes
in disordered eating symptoms, and alterations in body
image perception after 8 weeks of ADF in obese subjects.
Materials and methods
Subject selection
Obese subjects were recruited from the Chicago area by
advertisements. Key inclusion criteria were as follows:* Correspondence: varady@uic.edu
Department of Kinesiology and Nutrition, University of Illinois at Chicago,
1919 West Taylor Street, Room 506 F, Chicago, IL 60612, USA
© 2015 Hoddy et al.; licensee BioMed Central.
Commons Attribution License (http://creativec
reproduction in any medium, provided the or
Dedication waiver (http://creativecommons.or
unless otherwise stated.age 25–65 y, BMI between 30 and 39.9 kg/m [2], weight
stable, previously sedentary, non-diabetic, non-smoker,
and no history of cardiovascular disease. The experimental
protocol was approved by the Office for the Protection of
Research Subjects at the University of Illinois, Chicago,
and all volunteers gave written informed consent.
Study design and diet protocol
An 8-week trial was implemented to test the study ob-
jectives. The primary outcome measures were body
weight, adverse events, disordered eating symptoms, and
body image perception. Total energy expenditure was
quantified by the Mifflin equation [5] and appropriate
activity factors. All subjects consumed 25% of their base-
line energy needs on the fast day (24 h), and ate ad libi-
tum on each alternating feed day (24 h). Subjects were
provided with meals on each fast day, and ate ad libitum
on the feed day. All meals were consumed outside of the
research center. Fast day meals were provided as a 3-day
rotating menu, based on American Heart Association
(AHA) guidelines [6]. Body weight was measured using a
balance beam scale (HealthOMeter, Boca Raton, FL), and
body composition was assessed by dual energy X-ray
absorptiometry (DXA; iDXA, GE Inc.).This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,




Constipation (%) 17 17 1.00
Diarrhea (%) 0 0 1.00
Water retention (%) 2 2 1.00
Bad breath (%) 14 29 0.15
Sleep disturbances
Inability to fall asleep (%) 0 0 1.00
Inability to stay asleep (%) 7 2 0.50
Other adverse effects
Dizziness (%) 10 17 0.38
General weakness (%) 14 10 0.69
Values reported as mean % occurrences at each time point (n = 59).
1P-value between baseline and post-treatment: McNemar test.
Table 2 Changes in eating disorder symptoms and body
image perception after 8 weeks
Baseline Post-treatment P-value1
Eating disorder symptoms
Depression 27 ± 1 25 ± 1 0.01
Binge eating 33 ± 1 30 ± 1 <0.01
Purgative behavior 9 ± 1 9 ± 1 0.38
Fear of fatness 43 ± 2 43 ± 1 0.71
Restrictive eating 26 ± 1 31 ± 1 <0.01
Avoidance of forbidden foods 37 ± 2 39 ± 2 0.14
Body image
Concerns about body size/shape 53 ± 2 48 ± 2 <0.01
Values reported as mean ± SEM (n = 59).
1P-value between baseline and post-treatment: Paired t-test.
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questionnaires
An adverse event questionnaire was administered at base-
line (i.e. before the subjects began the intervention) and
post-treatment. Eating disorder symptoms were measured
using the Multidimensional Assessment of Eating-Disorder
Symptoms (MAEDS). The MAEDS is a validated [7]
self-report\ inventory that measures six symptom do-
mains related to eating disorders, including: binge eating,
restrictive eating, purgative behavior, fear of fatness, avoid-
ance of forbidden foods, and depression. Body image was
assessed by the Body Shape Questionnaire (BSQ). The
BSQ is a self-report questionnaire that measures excessive
concern about one’s body size and shape [8]. Higher
scores on the BSQ indicate greater concerns with body
size and shape.
Statistics
Results are presented as mean ± SEM. A paired t-test was
used to assess changes from baseline to post-treatment for
continuous variables, while a McNemar’s test was used for
categorical variables. Differences were considered signifi-
cant at P < 0.05. All data was analyzed using SPSS software
(version 21.0, SPSS Inc, Chicago, IL).
Results
Subject dropouts and weight loss
Seventy-four subjects began the study, and 59 subjects (age
46 ± 1 y) completed the 8-week trial. Reasons for dropouts
were as follows: inability to comply with the diet (n = 6),
scheduling conflicts (n = 2), personal reasons (n = 4), and
not specified (n = 3). Body weight decreased (P < 0.0001)
from 93.5 ± 1.4 kg to 89.7 ± 1.5 kg (−4.2 ± 0.3%) after
8 weeks of diet. Fat mass was reduced (P < 0.0001) from
41.3 ± 1.0 kg to 39.1 ± 1.0 kg, and visceral fat decreased
(P < 0.001) from 1.2 ± 0.1 kg to 1.1 ± 0.1 kg. Lean mass was
also reduced (P < 0.001) from 48.7 ± 1.1 kg to 47.3 ± 1.0 kg.
Adverse events
Constipation was experienced by 17% of subjects with
no change throughout the intervention period (Table 1).
There were no reports of diarrhea, and a small propor-
tion of subjects (2%) experienced water retention. Some
subjects reported bad breath at baseline (14%), and this
value doubled (29%) after 8 weeks, though not signifi-
cantly (P = 0.15). Inability to fall asleep was not reported,
though a small proportion of subjects (<10%) were un-
able to stay asleep. Dizziness and general weakness were
reported by some subjects (<15%), with no change after
8 weeks of diet.
Eating disorder symptoms and body image perception
Depression and binge eating decreased (P < 0.01) after
8 weeks of ADF (Table 2). Purgative behavior was low atbaseline and remained unchanged. Fear of fatness was mod-
erate, and did not change from baseline to post-treatment.
The intervention helped subjects increase (P< 0.01) restrict-
ive eating, but had no impact on avoidance of forbidden
foods. Body image perception improved (P< 0.01) from
baseline to post-treatment.Discussion
Subjects undergoing ADF experienced mild gastrointes-
tinal issues, occasional problems with staying asleep, and
minor dizziness/weakness. The rate of adverse events re-
ported with ADF appears to be similar to that of daily
calorie restriction. For instance, Cuevas et al. [9] and Lin
et al. [10] observed minimal adverse outcomes with 30-
50% restriction after 4–12 weeks (<15% of participants
reported constipation, diarrhea, or dizziness). In the
present study, the most commonly reported adverse
event was bad breath. However, this side effect may be
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and chewing sugar-free gum between meals.
As for eating disorder symptoms, ADF does not in-
crease the rate depression, binge eating, purgative behav-
iour, fear of fatness, or avoidance of forbidden foods,
and may have small beneficial effects on body image per-
ception. Interestingly, restrictive eating was moderately
increased with ADF, suggesting that the diet may help
control unrestrained eating behaviors [7]. These findings
for ADF are comparable to those of calorie restriction.
In a recent study by Williamson et al. [11], it was dem-
onstrated that 25% daily restriction did not increase eat-
ing disorder symptoms and had no other harmful
psychological effects. Taken together, it is possible that
neither ADF nor calorie restriction increase eating dis-
order symptoms in obese adults, but these findings re-
quire confirmation in a longer-term randomized control
trial comparing the two diets.
This study has several limitations. Firstly, the adverse
event questionnaire was not very comprehensive, and
was developed based on adverse events reported by sub-
jects in previous ADF trials conducted by our lab. Asses-
sing the impact of ADF on cold intolerance, hair loss,
headaches, muscle cramps, and difficultly concentrating,
would provide a more comprehensive portrayal of the
diet’s safety profile. Second, the intensity of these adverse
events (mild, moderate or severe) were not examined
and recorded. Third, much of the adverse event data re-
ported in this study was qualitative, and therefore may
underestimate all potential adverse events associated
with ADF. However, it should be noted that there is
mounting quantitative data from previous studies [1-4]
indicating that ADF may protect against the develop-
ment of cardiovascular and metabolic diseases. Thus, the
present data should be evaluated in the context of these
previous reports [1-4]. Fourth, this study is limited in
that it was short term (8 weeks), had a small sample size
(n = 59), and did not directly compare the effects of ADF
versus calorie restriction on these endpoints.
In summary, ADF appears to be a safe and effective
way to lose weight, and produces little or no gastrointes-
tinal, sleep, or energy level disturbances. We also show
here that this diet does not increase eating disorder
symptoms, and has benign or beneficial effects on body
image perception. These preliminary findings are an en-
couraging first step in this field, but obviously warrant
confirmation in a larger-scale, longer-term clinical trial.
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